INS and schizophrenia: Thus, cerebral insulin resistance in schizophrenia may induce reduced signal transduction for gamma-aminobutyric acid (GABA), N-methyl-d-aspartic acid (NMDA), dopamine-D2 receptors, and reduced levels of brain-derived neurotrophic factor (BDNF).